284 related articles for article (PubMed ID: 32631396)
1. Phantom simulation of liver metastasis on a positron emission tomography with computed tomography scan after neoadjuvant chemoradiotherapy for distal esophageal cancer: a case report.
Shai SE; Lin YH; Lai YL; Tang HW; Hsieh YW; Hung SC
J Med Case Rep; 2020 Jul; 14(1):106. PubMed ID: 32631396
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer : A retrospective study and literature review.
Voncken FEM; Aleman BMP; van Dieren JM; Grootscholten C; Lalezari F; van Sandick JW; Steinberg JD; Vegt E
Strahlenther Onkol; 2018 Feb; 194(2):156-163. PubMed ID: 29051991
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer.
Grant MJ; Didier RA; Stevens JS; Beyder DD; Hunter JG; Thomas CR; Coakley FV
Abdom Imaging; 2014 Oct; 39(5):963-8. PubMed ID: 24668312
[TBL] [Abstract][Full Text] [Related]
4. False Liver Metastasis by Positron Emission Tomography/Computed Tomography Scan after Chemoradiotherapy for Esophageal Cancer-Potential Overstaged Pitfalls of Treatment.
Shai SE; Lai YL; Chang CI; Hsieh CW
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473310
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Radiation-Induced Liver Injury Mimicking Metastatic Disease in a Patient With Esophageal Cancer: Correlation of Positron Emission Tomography/Computed Tomography With Magnetic Resonance Imaging and Literature Review.
Rabe TM; Yokoo T; Meyer J; Kernstine KH; Wang D; Khatri G
J Comput Assist Tomogr; 2016; 40(4):560-3. PubMed ID: 27023857
[TBL] [Abstract][Full Text] [Related]
7. Radiation Induced Liver Injury: Collateral Damage Radiologically Simulating Interval Metastasis in Carcinoma Esophagus; a Diagnostic Dilemma Resolved Through Liver Biopsy.
Bakshi N; Chand V; Sangal R; Duggal R
Int J Surg Pathol; 2022 Dec; 30(8):945-949. PubMed ID: 35470748
[TBL] [Abstract][Full Text] [Related]
8. Hepatic radiation injury mimicking metastasis in distal esophageal cancer
Demey K; Van Veer H; Nafteux P; Deroose CM; Haustermans K; Coolen J; Vandecaveye V; Coosemans W; Van Cutsem E
Acta Chir Belg; 2017 Aug; 117(4):250-255. PubMed ID: 27785973
[TBL] [Abstract][Full Text] [Related]
9. Hepatic radiation injury in distal esophageal carcinoma: a case report.
Wong JJ; Anthony MP; Lan Khong P
Clin Nucl Med; 2012 Jul; 37(7):709-11. PubMed ID: 22691523
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
Gabriel E; Alnaji R; Du W; Attwood K; Kukar M; Hochwald S
Ann Surg Oncol; 2017 Jun; 24(6):1739-1746. PubMed ID: 28058562
[TBL] [Abstract][Full Text] [Related]
11. PET/CT and hepatic radiation injury in esophageal cancer patients.
Iyer RB; Balachandran A; Bruzzi JF; Johnson V; Macapinlac HA; Munden RF
Cancer Imaging; 2007 Nov; 7(1):189-94. PubMed ID: 18055293
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
Gerbaudo VH; Killoran JH; Kim CK; Hornick JL; Nowak JA; Enzinger PC; Mamon HJ
Ann Nucl Med; 2018 Apr; 32(3):165-174. PubMed ID: 29332233
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
14. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
[TBL] [Abstract][Full Text] [Related]
15. Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns.
Betancourt Cuellar SL; Benveniste MF; Truong M; Nguyen QN; Atiyah A; Hofstetter WL; Erasmus JJ
Am J Clin Oncol; 2023 Jan; 46(1):25-30. PubMed ID: 36562692
[TBL] [Abstract][Full Text] [Related]
16. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
17. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Fatima N; Zaman MU; Zaman A; Zaman U; Tahseen R; Zaman S
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2003-2008. PubMed ID: 31350957
[TBL] [Abstract][Full Text] [Related]
18. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
[TBL] [Abstract][Full Text] [Related]
19. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
[TBL] [Abstract][Full Text] [Related]
20. PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
Yuan H; Tong DK; Vardhanabhuti V; Law SY; Chiu KW; Khong PL
Nucl Med Commun; 2016 Sep; 37(9):947-55. PubMed ID: 27145438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
